Concepedia

Ben Van Camp

BV

Statistics

Publications

39

Citations

3.3K

H-Index

28

Active since

1986

Affiliations

Vrije Universiteit Brussel(Current)

University of Sheffield

Universitair Ziekenhuis Brussel

University of Antwerp

Tianjin Medical University General Hospital

Ben Van Camp is an author at Vrije Universiteit Brussel specializing in multiple myeloma, medicine, and myeloma pathogenesis.

Publications per year

1986–2013

39

Publications

39

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Shaji Kumar, J H Lee, Juan José Lahuerta et al. · Leukemia · 2011 · 721 citations

, , +15

Zoledronic Acid Treatment of 5T2MM-Bearing Mice Inhibits the Development of Myeloma Bone Disease: Evidence for Decreased Osteolysis, Tumor Burden and Angiogenesis, and Increased Survival

Peter I. Croucher, Hendrik De Raeve, Mark Perry et al. · Journal of Bone and Mineral Research · 2003 · 267 citations · Full text

, , +17

Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma.

Karin Vanderkerken, Evy De Leenheer, C M Shipman et al. · PubMed · 2003 · 189 citations

, , +17

Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug

Jinsong Hu, Damian Handisides, Els Van Valckenborgh et al. · Blood · 2010 · 156 citations

, , +14

Evidence that the clonogenic cell in multiple myeloma originates from a pre‐switched but somatically mutated B cell

Marleen Bâkkus, Ivan Van Riet, Ben Van Camp et al. · British Journal of Haematology · 1994 · 145 citations

, , +17

1–5 of 39